Published in Cytometry on April 01, 1996
Changes in platelet functional parameters and CD62 P expression in liver cirrhosis. Afr Health Sci (2013) 0.99
Redistribution and hemostatic action of recombinant activated factor VII associated with platelets. Am J Pathol (2011) 0.85
Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum (1995) 2.48
Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants. J Pediatr (1996) 1.80
Laboratory testing for thrombophilia in pediatric patients. On behalf of the Subcommittee for Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis (ISTH). Thromb Haemost (2002) 1.56
Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children. Br Heart J (1993) 1.43
Relationship between thrombin generation and carotid intima-media thickness. Hamostaseologie (2010) 1.40
A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity. Blood (1982) 1.12
Recommendations for tPA thrombolysis in children. On behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost (2002) 1.05
Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia. Pediatrics (1995) 1.01
Longer aPTT values in healthy children than in adults: no single cause. Thromb Res (1997) 0.97
Lupus anticoagulant and factor XII activity in children with prolonged PTT. Thromb Res (1996) 0.97
Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost (2003) 0.96
[Loss of inhibitors of the blood coagulation system in protein-losing enteropathy (author's transl)]. Klin Padiatr (1979) 0.92
Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke. Thromb Haemost (1998) 0.90
The role of inherited thrombotic disorders in the etiology of Legg-Calvé-Perthes disease. J Pediatr Orthop (1999) 0.90
Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma. J Thromb Haemost (2003) 0.88
Influence of high molecular weight factor VIII on the measurement of low molecular weight factor VIII procoagulant in different assay systems. Br J Haematol (1982) 0.87
Severe bleeding due to factor V inhibitor after repeated operations using fibrin sealant containing bovine thrombin. Thromb Haemost (1997) 0.86
Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates. Blood (1988) 0.85
Respective roles of factors II, VII, IX, and X in the procoagulant activity of FEIBA. Blood Coagul Fibrinolysis (2002) 0.84
Haemostatic alterations in overweight children: associations between metabolic syndrome, thrombin generation, and fibrinogen levels. Atherosclerosis (2010) 0.84
Thrombin generation in severely obese children. J Thromb Haemost (2006) 0.83
Danaparoid sodium (Orgaran) in four children with heparin-induced thrombocytopenia type II. Acta Paediatr (2001) 0.82
Heparin inhibition of the cytostatic effect of Adriamycin on cultured lymphocytes. Acta Haematol (1981) 0.82
Haemostatic changes in tall girls treated with high doses of ethinyloestradiol. Eur J Pediatr (1980) 0.81
Determinants of haemostatic risk factors for coronary heart disease in obese children and adolescents. Int J Obes Relat Metab Disord (2000) 0.81
Thrombin generation in factor VIII-depleted neonatal plasma: nearly normal because of physiologically low antithrombin and tissue factor pathway inhibitor. J Thromb Haemost (2006) 0.81
Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries. Haemophilia (2000) 0.81
Malignant stroke in an adolescent with a homozygous MTHFR 677CT mutation and intake of hormonal contraceptives. Hamostaseologie (2009) 0.80
Effects of short-term energy restriction and physical training on haemostatic risk factors for coronary heart disease in obese children and adolescents. Int J Obes Relat Metab Disord (2001) 0.80
Plasma concentrations after intravenous administration of phylloquinone (vitamin K(1)) in preterm and sick neonates. Thromb Res (2000) 0.80
Hyporeactivity of neonatal platelets is not caused by preactivation during birth. Eur J Pediatr (1997) 0.80
Effect of heparin, platelets, activated platelets, platelet fragments, and hematocrit on activated clotting time. Artif Organs (2000) 0.79
Activation of the haemostatic system in children with juvenile rheumatoid arthritis correlates with disease activity. Thromb Res (1998) 0.79
Shorter PFA-100 closure times in neonates than in adults: role of red cells, white cells, platelets and von Willebrand factor. Acta Paediatr (2001) 0.79
Recombinant factor VIIa does not induce hypercoagulability in vitro. Thromb Haemost (1999) 0.78
Method for the determination of vitamin K1(20) in human plasma by stable isotope dilution/gas chromatography/mass spectrometry. J Mass Spectrom (1996) 0.78
Screening for haemorrhagic disorders in paediatric patients by means of a questionnaire. Hamostaseologie (2009) 0.78
More on: mild hemophilia A and inhibitor development. J Thromb Haemost (2004) 0.78
Normalization of haemostatic alterations in overweight children with weight loss due to lifestyle intervention. Atherosclerosis (2011) 0.78
No differences in support of thrombin generation by neonatal or adult platelets. Hamostaseologie (2009) 0.77
Newborn platelets: lower levels of protease-activated receptors cause hypoaggregability to thrombin. Platelets (2010) 0.77
Regular smoking is not associated with increased thrombin generation in young adults. J Thromb Haemost (2013) 0.77
Activation of the clotting system: heparin-coated versus non coated systems for extracorporeal circulation. Int J Artif Organs (1997) 0.77
Diagnostic and therapeutic considerations on inherited platelet disorders in neonates and children. Klin Padiatr (2010) 0.77
Severely depressed natural killer cell activity of patients with adrenoleukodystrophy under treatment with Lorenzo's oil. J Inherit Metab Dis (1995) 0.77
High titre inhibitor after continuous factor VIII administration for surgery in a young infant. Haemophilia (2000) 0.77
Comparative evaluation of PAR1, GPIb-IX-V, and integrin αIIbβ3 levels in cord and adult platelets. Hamostaseologie (2010) 0.76
Demonstration of Epstein-Barr virus DNA in a previously healthy boy with fulminant hepatic failure. Eur J Pediatr (1986) 0.76
[Fetal alcohol syndrome and malignant tumors]. Wien Klin Wochenschr (1982) 0.76
A novel type of mutation at the propeptide cleavage site (AlA+1Thr) causing symptomatic protein C type II deficiency. Thromb Res (2000) 0.76
Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents. Metabolism (2000) 0.76
The influence of weight loss on fibrinolytic and metabolic parameters in obese children and adolescents. J Pediatr Endocrinol Metab (2001) 0.76
Giant platelets in erucic acid therapy for adrenoleukodystrophy. Lancet (1993) 0.76
Portal vein thrombosis in a 17-year-old female adolescent with essential thrombocytosis. Pediatr Hematol Oncol (1997) 0.76
In vivo thrombin generation in neonates. J Thromb Haemost (2004) 0.75
Correlation between cholesterol, soluble P-selectin, and D-dimer in obese children and adolescents. Blood Coagul Fibrinolysis (2000) 0.75
Cutaneous necrosis associated with acquired severe protein S deficiency. Thromb Haemost (1994) 0.75
Calibrated automated thrombin generation in paediatric patients with inflammatory bowel disease. Hamostaseologie (2009) 0.75
Antiphospholipid antibodies in children. Thromb Res (2001) 0.75
[Factor VIII activity and factor VIII associated antigen in newborns (author's transl)]. Klin Padiatr (1977) 0.75
[Disseminated intravascular coagulation in Reye's syndrome (author's transl)]. Wien Klin Wochenschr (1977) 0.75
[Exchange transfusion in sepsis of the nerborn infant. 8-year retropsective study. Infectin and immunology-oriented deliberations]. Monatsschr Kinderheilkd (1977) 0.75
[Intracranial hemorrhage in idiopathic thrombocytopenic purpura (ITP) (author's transl)]. Klin Padiatr (1976) 0.75
Hemorrhagic complications of L-asparaginase therapy. J Pediatr (1983) 0.75
Immunologic studies of prothrombin in newborns. Pediatr Res (1979) 0.75
[Recognition of bacterial infections in newborns by measuring specific antibody-titres (author's transl)]. Monatsschr Kinderheilkd (1978) 0.75
Alpha-2-macroglobulin inhibits the anticoagulant action of activated protein C in cord and adult plasma. Haemostasis (2001) 0.75
[Change of plasmatic blood coagulation factors by exchange transfusion using heparin and ACD blood in newborn infants]. Monatsschr Kinderheilkd (1979) 0.75
[Pseudo-Perthes' disease caused by acute lymphatic leukemia]. Padiatr Padol (1983) 0.75
[Biphasic splenic rupture in a hemophilic child (author's transl)]. Padiatr Padol (1981) 0.75
[You make the diagnosis: hypohidrotic ectodermal dysplasia]. Padiatr Padol (1983) 0.75
Thrombin generation in paediatric patients with congenital heart disease. Determination by calibrated automated thrombography. Hamostaseologie (2008) 0.75
Platelets contain interleukin-1 alpha and beta which are detectable on the cell surface after activation. Scand J Immunol (1995) 0.75
[Haemostasis in premature and newborn babies (author's transl)]. Padiatr Padol (1980) 0.75
Effects of growth hormone on the factor VIII complex in patients with growth hormone deficiency. Metabolism (1984) 0.75
[Make your own diagnosis]. Padiatr Padol (1979) 0.75
Hemorrhagic diathesis from transiently acquired Factor VIII complex deficiency. J Pediatr (1981) 0.75
High microparticle concentration in cord plasma. Hamostaseologie (2010) 0.75
[Coagulation studies from capillary blood in newborn infants]. Helv Paediatr Acta (1976) 0.75
[Is the DDAVP-test helpful to diagnose children?]. Hamostaseologie (2010) 0.75
Arthralgia and digital clubbing in a child: hypertrophic osteoarthropathy with inflammatory pseudotumour of the lung. Scand J Rheumatol (2004) 0.75
[What is your diagnosis? Transient erythroblastopenia of childhood]. Padiatr Padol (1982) 0.75
[Austrian haemophilia registry: up-date 2008 ]. Hamostaseologie (2009) 0.75
[Relevance of a single dose of 270 microg/kg recombinant factor VIIa for the treatment of patients with haemophilia and inhibitors - Recommendations from the GTH experts]. Hamostaseologie (2009) 0.75
Fetal alcohol syndrome and malignant disease. Eur J Pediatr (1984) 0.75
Lupus anticoagulant after measles. Eur J Pediatr (1980) 0.75
[Pernio as cause of a blue toe syndrome]. Klin Padiatr (2006) 0.75
Port-A-Cath infection causes inhibitor recurrence after initial successful ITI. Haemophilia (2013) 0.75
Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma. Thromb Haemost (1995) 0.75
[Disseminated intravascular coagulation and acute renal failure in an infant. Treated with streptokinase and peritoneal dialysis (author's transl)]. Wien Klin Wochenschr (1975) 0.75
[Hemostasis in hereditary hemorrhagic telangiectasia (author's transl)]. Padiatr Padol (1978) 0.75
[Ketamine anesthesia for outpatient procedures in children (author's transl)]. Monatsschr Kinderheilkd (1980) 0.75
[Thrombasthenia in a newborn (author's transl)]. Padiatr Padol (1979) 0.75
[What is your diagnosis?]. Padiatr Padol (1980) 0.75
Enhanced thrombin generation in plasma of severe thrombocytopenic patients due to rFVIIa. Hamostaseologie (2008) 0.75
[What is your diagnosis? (Primary familial renal glycosuria)]. Padiatr Padol (1980) 0.75
[Make your own diagnosis]. Padiatr Padol (1978) 0.75
Reye's syndrome. Am J Dis Child (1980) 0.75
[Vitamin K deficiency in the newborn]. Wien Klin Wochenschr (1983) 0.75
[Thrombocytopenia and IgA deficiency]. Padiatr Padol (1984) 0.75